Stay updated on Nivolumab & Lenalidomide in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Lenalidomide in Lymphoma Clinical Trial page.

Latest updates to the Nivolumab & Lenalidomide in Lymphoma Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded Locations: Georgia and Ohio (Locations) and updated page to revision v3.3.3; removed HHS Vulnerability Disclosure and prior Georgia/Ohio Locations entries (revision v3.3.2).SummaryDifference0.3%

- Check54 days agoChange DetectedA new revision labeled v3.3.2 has been added to the page's revision history, replacing the previous v3.2.0. This change is limited to version metadata and does not modify the study content or functionality.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the bottom notice about government funding and NIH operating status. This change does not affect trial details, eligibility criteria, outcomes, or contact information.SummaryDifference0.4%

- Check75 days agoChange DetectedDifference0.4%

- Check104 days agoChange DetectedMajor: Update of operating status notice, new future dates, and new revision/version (v3.2.0); removal of prior dates and older revision (v3.1.0).SummaryDifference3%

Stay in the know with updates to Nivolumab & Lenalidomide in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Lenalidomide in Lymphoma Clinical Trial page.